These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27894399)

  • 21. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways.
    Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F
    Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats].
    Ding CZ; Yao Y; Fang Y; Sun LY; Wang Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):256-60. PubMed ID: 23646485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK
    Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Enterococcus faecalis lipoteichoic acid on receptor activator of nuclear factor-κB ligand and osteoprotegerin expression in periodontal ligament fibroblasts.
    Zhao L; Chen J; Cheng L; Wang X; Du J; Wang F; Peng Z
    Int Endod J; 2014 Feb; 47(2):163-72. PubMed ID: 23710898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
    Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of triptolide on expression of receptor activator of nuclear factor-kappaB ligand in rat adjuvant induced arthritis.
    Hu Y; Luo B; Zhang M; Tu S; Zeng K
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):344-6. PubMed ID: 16961289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Effect of Matrine on Collagen-Induced Arthritis Rats and Its Regulatory Effect on RANKL and OPG Expression.
    Li X; Zhang L; Xu Y; Zhao D; Mu L; Zhang B; Ke J
    J Immunol Res; 2021; 2021():4186102. PubMed ID: 34423052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH
    Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
    Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iguratimod in combination with methotrexate in active rheumatoid arthritis : Therapeutic effects.
    Xia Z; Lyu J; Hou N; Song L; Li X; Liu H
    Z Rheumatol; 2016 Oct; 75(8):828-833. PubMed ID: 26508503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of sinomenine and methotrexate on fibroblast-like synoviocytes in rheumatoid arthritis].
    Sun Y; Ding CZ; Yao Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Aug; 32(8):1107-11. PubMed ID: 23173263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.
    Li CH; Xu LL; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Yang L; Xing R; Liu XY
    Inflamm Res; 2016 Mar; 65(3):193-202. PubMed ID: 26621504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients.
    Hidayat R; Isbagio H; Setyohadi B; Setiati S
    Acta Med Indones; 2014 Jan; 46(1):24-9. PubMed ID: 24760805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling.
    Bergström B; Selldén T; Bollmann M; Svensson MND; Ekwall AH
    Arthritis Res Ther; 2024 Oct; 26(1):178. PubMed ID: 39394168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
    Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
    Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
    Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
    Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis.
    Remuzgo-Martínez S; Genre F; López-Mejías R; Ubilla B; Mijares V; Pina T; Corrales A; Blanco R; Martín J; Llorca J; González-Gay MA
    Sci Rep; 2016 Jul; 6():29713. PubMed ID: 27403809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.